The trial will compare the effects of PPS subcutaneous injections to placebo on pain and function. In the Phase III clinical trial of injectable pentosan polysulfate sodium (PPS/Zilosul) for the treatment of pain associated with Osteoarthritis Drugs Development Market in the United States, Paradigm Biopharmaceuticals has randomized and dosed the first participants. The trial's first subject was...